M. Montagne

Effects of olomoucine, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines.

F. Lallemand, C. Buquet-Fagot, M. Montagne, 1997, Anti-cancer drugs.

Sodium butyrate induces G2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for DNA rereplication.

F. Lallemand, A. Atfi, C. Buquet-Fagot, 1999, Experimental cell research.

Hyperprolactinemia-induced modifications in vasoactive intestinal peptide binding site densities in the rat central nervous system and pituitary gland: evidence for an interaction between estradiol-17β and prolactin effects

M. Montagne, W. Rostène, M. Vial, 1989, Brain Research.

Changes in Vasoactive Intestinal Peptide Binding Site Densities in the Female Rat Central Nervous System and Pituitary During Lactation

M. Meaney, V. Viau, M. Montagne, 1992, Journal of neuroendocrinology.

Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density

D. Scherman, M. Montagne, W. Rostène, 1990, Brain Research.

Estradiol Induces Vasoactive Intestinal Peptide and Prolactin Gene Expression in the Rat Anterior Pituitary Independently of Plasma Prolactin Levels

M. Montagne, W. Rostène, L. Chew, 1995, Journal of neuroendocrinology.

Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density

D. Scherman, M. Montagne, W. Rostène, 1990, Brain Research.